Rengraf 1 Capsule
By Rengraf
Rx
10 Capsule in a Strip

Composition
Tacrolimus(1mg)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
August, 2025

liver
When taking Rengraf 1 Capsule, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to the dosage of the capsule. It is highly recommended to consult your doctor before using Rengraf 1 Capsule to ensure the appropriate dosage and safety for your liver health.

kidney
Rengraf 1 Capsule requires caution in patients with kidney disease. Dosage adjustment might be necessary. Please consult your doctor.

alcohol
It is not recommended to drink alcohol while taking Rengraf 1 Capsule due to safety concerns.

driving
When taking Rengraf 1 Capsule, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Rengraf 1 Capsule could potentially be harmful during pregnancy based on animal studies. Limited human studies are available. Consult your doctor for a personalized assessment considering the risks and benefits before using this medication.

breastfeeding
**Safety Advice - Breastfeeding** Rengraf 1 Capsule is considered unsafe during breastfeeding. Limited data suggests it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Macrolide Lactams |
Therapeutic Class | - |
Action Class | Immunosuppressant- Calcineurin inhibitors |
₹434.97
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024